ADx Healthcare is selling an APOE test on the Helix marketplace, while HealthLytix and Dash Genomics are marketing a polygenic hazard score for late-onset Alzheimer's.

The report advises that although sequencing the genomes of infants can be appropriate in some specific cases, we shouldn’t implement large-scale programs to test healthy babies.

A workflow developed by the company along with Max Planck researchers demonstrates the system's potential for enabling high-throughput proteomic experiments.

The program was established to support the development and dissemination of functional genomic tools and techniques for genome manipulation in model organisms.

A brief recap of Genetics/Genomics news the week of Aug 31, 2018: Perosnalize Medicine Coalition, Enzo Biochem, Hoosier Cancer Research Network, Scor Global Life, and ALCF

The project aims to use circulating tumor DNA to monitor drug response and resistance in metastatic melanoma patients in order to guide treatment decisions.

Commercial genetic tests are bringing together biological children of fertility doctor who slipped patients his own sperm.

The method combines stable isotope dimethyl labeling with DiLeu isobaric tagging and allows multiplexing of up to 24 samples in a single mass spec experiment.

One of the largest repositories of molecular brain cancer data in the world, the enhanced REMBRANDT is more comprehensive than an earlier NCI-hosted version.

The researchers say that methods that include gene expression as well as other genomic data in one assay could help unravel cell function and gene regulation.

Dreams just might stem from two genes, according to a new mouse study.

After a series of duplication and rearrangement events, the genes involved in two key pathways producing morphine, codeine, and noscapine have clustered in the genome.

The Boston Globe describes facial recognition software designed to help diagnose rare genetic conditions.

The opium poppy genome, gene editing in Duchenne muscular dystrophy, and complex Ewing sarcoma rearrangements.

Veracyte said that the draft policy is open to a 45-day comment period and could potentially go into effect in early 2019.

The firm's automated AIR sample prep technology quickly images, sorts, and isolates single cells for downstream molecular analysis.

The results suggest that some Ewing sarcomas could be detected earlier, when they are easier to treat.

The ability to effectively use FFPE tissue opens up a large number of clinical samples for analysis, many with quality data on patient demographics, treatment, and outcomes.

The firm will use the agreement to access alternative non-dilutive means of financing of its growth plans.

The New York Times profiles a genetic genealogist who helped nab the Golden State Killer.

In Medium, George Church talks Nebula Genomics and the potential benefits of personal genome sequencing.

Using data for more than 500,000 individuals, researchers found 15 fracture-linked loci and saw genetic interactions between fracture and bone mineral density.

Nature News looks at strategies for restoring lost woodlands.